{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:00:43Z","timestamp":1786737643860,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Reprod Sci"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/jhrs.jhrs_96_20","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T11:30:24Z","timestamp":1616931024000},"page":"21","source":"Crossref","is-referenced-by-count":17,"title":["Do basal luteinizing hormone and luteinizing hormone\/follicle-stimulating hormone ratio have significance in prognosticating the outcome of In vitro fertilization cycles in polycystic ovary syndrome?"],"prefix":"10.4103","volume":"14","author":[{"given":"Yogita","family":"Dogra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-1208.312454-1","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.312454-2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(00)01701-5","article-title":"A randomised prospective assessor-blind evaluation of luteinising hormone dosage and in vitro fertilisation outcome","author":"Gordon","year":"2001","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.312454-3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/humrep\/17.4.1017","article-title":"Follicular fluid markers of oocyte developmental potential","author":"Mendoza","year":"2002","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-4","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/bmj.312.7045.1508","article-title":"Does suppressing luteinising hormone secretion reduce the miscarriage rate.Results of a randomised controlled trial?","author":"Clifford","year":"1996","journal-title":"BMJ"},{"key":"key-10.4103\/0974-1208.312454-5","first-page":"41","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","author":"Rotterdam","year":"2004","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-6","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.fertnstert.2013.07.1976","article-title":"Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles","author":"Lin","year":"2013","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.312454-8","first-page":"1","article-title":"Effect of high LH\/FSH ratio on women with PCOS undergoing IVM treatment","author":"Wiser","year":"2013","journal-title":"J Reprod Med"},{"key":"key-10.4103\/0974-1208.312454-9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"The influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in patients with polycystic ovary syndrome","author":"Homburg","year":"1988","journal-title":"Br Med J"},{"key":"key-10.4103\/0974-1208.312454-10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.18203\/2320-1770.ijrcog20175869","article-title":"The effect of baseline serumluteinizing hormone levels on follicular development, ovulation, conception and pregnancy outcome in infertile patients with polycystic ovarian syndrome","author":"Shanmugham","year":"2017","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"key-10.4103\/0974-1208.312454-11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrendo.2014.102","article-title":"The management of patients with polycystic ovary syndrome","author":"Jayasena","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"key-10.4103\/0974-1208.312454-12","first-page":"755","article-title":"The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome","author":"van","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key-10.4103\/0974-1208.312454-13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bmj.297.6655.1027","article-title":"Recurrent early miscarriage and polycystic ovaries","author":"Sagle","year":"1988","journal-title":"BMJ"},{"key":"key-10.4103\/0974-1208.312454-14","first-page":"15","article-title":"A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in-vitro fertilisation embryo transfer program.J Assist Report Genet","author":"Turhan","year":"1993","journal-title":""},{"key":"key-10.4103\/0974-1208.312454-15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/humrep\/7.suppl_1.49","article-title":"The use of gonadotrophin releasing hormone agonists for in vitro fertilisation and other assisted procreation techniques: experience from three centres","author":"Smitz","year":"1992","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: A Cochrane review","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-17","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3892\/etm.2017.4309","article-title":"GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilisation and embryo transfer in fresh cycles","author":"Zhai","year":"2017","journal-title":"Exp Ther Med"},{"key":"key-10.4103\/0974-1208.312454-18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hyper secretion of luteinising hormone, infertility, and miscarriage","author":"Regan","year":"1990","journal-title":"Lancet"},{"key":"key-10.4103\/0974-1208.312454-19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/09513590.2011.633661","article-title":"Does day-3 LH\/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?","author":"Orvieto","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"key-10.4103\/0974-1208.312454-20","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1093\/oxfordjournals.humrep.a135742","article-title":"The prognostic value of basal luteinizing hormone: follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques","author":"Tarlatzis","year":"1995","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-21","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/dex319","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: An RCT.Part 2: The predicted hyper responder","author":"Oudshoorn","year":"2017","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-22","doi-asserted-by":"crossref","unstructured":"Nyboe Andersen A, Nelson SM, Fauser BC, Garc\u00eda-Velasco JA, Klein BM, Arce JC, et al. Individualized versus conventional ovarian stimulation for in vitro fertilization: A multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril 2017;107:387-396.e4.","DOI":"10.1016\/j.fertnstert.2016.10.033"},{"key":"key-10.4103\/0974-1208.312454-23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s40618-015-0429-x","article-title":"What is the best treatment for women with polycystic ovarian syndrome and high LH\/FSH ratio.A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation?","author":"Ganor-Paz","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"key-10.4103\/0974-1208.312454-24","first-page":"857","article-title":"Effect of basal serum luteinising hormone and luteinising hormone\/follicle-stimulating hormone ratio on outcomes of in vitro fertilisation-embryo transfer in patients with polycystic ovarian syndrome","author":"Geng","year":"2013","journal-title":"Nan Fang Yi Ke Da XueXue Bao"},{"key":"key-10.4103\/0974-1208.312454-25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-0528.1985.tb01113.x","article-title":"Reduced in-vitro fertilisation of human oocytes from patients with raised basal luteinising hormone levels during the follicular phase","author":"Stanger","year":"1985","journal-title":"BJOG"},{"key":"key-10.4103\/0974-1208.312454-26","first-page":"1438","article-title":"Nongenomic effects of 17beta-estradiol on maturing human oocytes: Relationship to oocyte developmental potential","author":"Tesarik","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.312454-27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humupd\/3.2.95","article-title":"Direct non-genomic effects of follicular steroids on maturing human oocytes: Oestrogen versus androgen antagonism","author":"Tesarik","year":"1997","journal-title":"Hum Reprod Update"},{"key":"key-10.4103\/0974-1208.312454-28","unstructured":"Gardner DK, Weissman A, Howles CM, Shoham Z. Endocrine characteristics of assisted reproduction technology cycles. In: Textbook of Assisted Reproductive Techniques. Vol. 2., Ch. 41., 5th ed. Boca Raton: CRC Press; 2018. p. 534-5."},{"key":"key-10.4103\/0974-1208.312454-29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humrep\/dez023","article-title":"Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise","author":"Friis","year":"2019","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.312454-30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1477-7827-9-112","article-title":"Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF","author":"Biasoni","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"key-10.4103\/0974-1208.312454-31","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1471-0528.1989.tb03232.x","article-title":"Do raised serum luteinising hormone levels during stimulation for in-vitro fertilisation predict outcome?","author":"Thomas","year":"1989","journal-title":"BJOG"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:57:15Z","timestamp":1786733835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_96_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["312454"],"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_96_20","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}